Gomes J., Marcos N.T., Berois N., Osinaga E., Magalhaes A., Pinto-de-Sousa J., Almeida R., Gartner F., Reis C.A.

J. Histochem. Cytochem. 57:79-86(2009) GeneRIF 11226 · Mapped (5)
ppGalNAc-T6 is an IHC marker associated with venous invasion in gastric carcinoma and may contribute to the understanding of the molecular mechanisms that underlie aberrant glycosylation in gastric carcinogenesis and in gastric carcinoma. GeneRIF 11226

Patani N., Jiang W., Mokbel K.

Cancer Genomics Proteomics 5:333-340(2008) GeneRIF 11226 · Mapped (9)
Expression of ppGalNAc-T6 is significantly higher in breast cancer compared to 'normal'/benign breast tissue samples. ST6GalNAc-I expression in breast cancer is associated with better prognosis. GeneRIF 11226

Rose J.E., Behm F.M., Drgon T., Johnson C., Uhl G.R.

Mol. Med. 16:247-253(2010) GeneRIF 11226 · Mapped (10,283)
Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator) GeneRIF 11226

Park J.H., Katagiri T., Chung S., Kijima K., Nakamura Y.

Neoplasia 13:320-326(2011) GeneRIF 11226 · Mapped (5)
GALNT6-fibronectin pathway should be a critical component for breast cancer development and progression. GeneRIF 11226